Opportunity ID: 200734

General Information

Document Type:: Grants Notice
Funding Opportunity Number:: RFA-AG-13-010
Funding Opportunity Title:: Caenorhabditis Intervention Testing Program (CITP) U01
Opportunity Category:: Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity:: Health
Category Explanation::
Expected Number of Awards:: 3
Assistance Listings Number(s):: 93.866 — Aging Research
Cost Sharing or Matching Requirement:: No
Version:: Synopsis 1
Posted Date:: Sep 11, 2012
Last Updated Date::
Original Closing Date for Applications:: Nov 07, 2012
Current Closing Date for Applications:: Nov 07, 2012
Archive Date:: Dec 08, 2012
Estimated Total Program Funding:: $ 1,500,000
Award Ceiling:: $350,000
Award Floor:: $

Eligibility

Eligible Applicants:: Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility:: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed

Additional Information

Agency Name:: National Institutes of Health
Description:: The National Institute on Aging (NIA) invites applications for cooperative agreements (U01s) from investigators or groups of investigators (e.g., multiple PD(s)/PI(s) capable of, and interested in, participating in a Caenorhabditis Intervention Testing Program (CITP). The goal is to identify pharmacological interventions that increase lifespan and/or healthspan in a robust manner when tested using multiple species of the simple invertebrate Caenorhabditis and/or multiple strains of Caenorhabditis elegans. Human populations are genetically heterogeneous and thus, in order to work in humans, any intervention that extends lifespan/healthspan needs to do so within a variety of genetic backgrounds. Testing of promising compounds in a variety of genetic backgrounds within a species with a short, well-studied lifespan and healthspan, should accelerate the current rate of discovery.
Link to Additional Information::
Grantor Contact Information:: If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version Modification Description Updated Date
Synopsis 1

Package

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Packages

Assistance Listings Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions Who Can Apply:
93.866 ADOBE-FORMS-B2 Adobe-Forms-B2 PKG00146311 Oct 05, 2012 Nov 07, 2012 View Grants Info Organization Applicants